In a zebrafish model of autism, CBD reversed hyperactivity and aggression more effectively than risperidone, while also addressing underlying neurobiological changes.
Researchers studying cannabinoids in neurodevelopmental conditions; families following CBD research for autism
CBD normalized both glial markers and excitatory/inhibitory balance where risperidone did not
What the researchers found
CBD treatment reversed VPA-induced hyperlocomotion and aggression in zebrafish, reduced lipid peroxidation, restored anandamide levels, and normalized markers of glial function. Risperidone showed limited behavioral improvement and did not affect these neurobiological markers.
Why it matters
Risperidone is one of only two FDA-approved medications for autism-related irritability, but it comes with significant side effects. This study suggests CBD may address not just behavioral symptoms but some of the underlying neurobiology.
The numbers in context
CBD at 0.06 microM reversed both hyperlocomotion and aggression. CBD reduced lipid peroxidation and restored anandamide levels. CBD normalized both GFAP and calcium/calmodulin expression.
How the study worked
Zebrafish embryos were exposed to sodium valproate (VPA) to induce autism-like features. At 3-4 days post-fertilization, embryos were treated with 0.06 microM CBD or 1 microM risperidone.
What this study cannot tell us
Zebrafish model cannot replicate full complexity of human autism. VPA-induced autism model represents only one possible pathway to ASD. Results cannot be directly translated to human dosing.
How to read the evidence
Animal study in zebrafish; preclinical evidence that requires validation in mammalian models and human trials.
When this study was published
2025 study with current preclinical methods
The bigger picture
The endocannabinoid system plays an established role in neurodevelopment. This zebrafish study adds to preclinical evidence suggesting cannabinoids may have therapeutic potential in neurodevelopmental conditions.
Questions still open
- Would these results hold in mammalian autism models? What dose of CBD in humans would correspond to the concentrations used here?
Common questions
Does this mean CBD can treat autism in humans?
Why did CBD work better than risperidone in this model?
Read the original research
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate.
Autism research : official journal of the International Society for Autism Research, 18(12), 2368-2381
Citation
Costa, Karla C M; Brigante, Tamires A V; Lirio, Pedro H C; Fernandes, Gabriel G; Scarante, Franciele F; Scomparin, Davi S; Ferreira, Rafael R; Vicente, Maria A; Abe, Flavia R; Guimarães, Francisco S; Hallak, Jaime E C; Crippa, Jose A; de Oliveira, Danielle P; Campos, Alline C. (2025). Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate.. Autism research : official journal of the International Society for Autism Research, 18(12), 2368-2381. https://doi.org/10.1002/aur.70151
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk